Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SARS-Coronavirus Nucleocapsid Protein Produkte

(SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N))
Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. {ECO:0000250|UniProtKB:P03417, ECO:0000269|PubMed:17210170}.

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte SARS-Coronavirus Nucleocapsid Protein Kategorien

SARS-Coronavirus Nucleocapsid Protein Antikörper

High quality antibodies with extensive validation data.

SARS-Coronavirus Nucleocapsid Protein Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene SARS-Coronavirus Nucleocapsid Protein Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Applikation ELISA, WB, IF, FACS, FISH, IHC
Validierungen
  • (13)
  • (14)
Kat. Nr. ABIN6952544
Menge 500 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Applikation ELISA, WB
Validierungen
  • (1)
Kat. Nr. ABIN6952441
Menge 100 μL
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Applikation ELISA, WB
Validierungen
Kat. Nr. ABIN7383874
Menge 50 μL
Datenblatt Datenblatt

Empfohlene SARS-Coronavirus Nucleocapsid Protein Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source HEK-293 Cells
Validierungen
  • (2)
Kat. Nr. ABIN7013145
Menge 100 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7197788
Menge 50 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7385288
Menge 20 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren SARS-Coronavirus Nucleocapsid Protein Produkten

Pedersen, Koumakpayi, Babuadze, Baz, Ndiaye, Faye, Diagne, Dia, Naghibosadat, McGeer, Muberaka, Moukandja, Ndidi, Tauil, Lekana-Douki, Loucoubar, Faye, Sall, Magalhães, Weis, Kozak, Kobinger et al.: "Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic. ..." in: Scientific reports, Vol. 12, Issue 1, pp. 12962, (2022) (PubMed).

Ge, Wang, Ju, Zhang, Sun, Chen, Zhang, Tian, Shan, Cheng, Zhou, Song, Zhao, Wang, Shi, Ding, Liu, Zhao, Zhang, Wang, Zhang: "Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry." in: Nature communications, Vol. 12, Issue 1, pp. 250, (2021) (PubMed).

Fattori, Cribier, Chenard, Mitcov, Mayeur, Weingertner: "Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings." in: Human pathology, Vol. 107, pp. 39-45, (2021) (PubMed).

Cervia, Nilsson, Zurbuchen, Valaperti, Schreiner, Wolfensberger, Raeber, Adamo, Weigang, Emmenegger, Hasler, Bosshard, De Cecco, Bächli, Rudiger, Stüssi-Helbling, Huber, Zinkernagel, Schaer, Aguzzi et al.: "Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. ..." in: The Journal of allergy and clinical immunology, Vol. 147, Issue 2, pp. 545-557.e9, (2021) (PubMed).

Zhu, Feng, Hu, Wang, Yu, Zhu, Xu, Cai, Sun, Han, Ye, Qu, Ding, Huang, Chen, Xu, Xie, Cai, Yuan, Zhang: "A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry." in: Nature communications, Vol. 12, Issue 1, pp. 961, (2021) (PubMed).

Hekman, Hume, Goel, Abo, Huang, Blum, Werder, Suder, Paul, Phanse, Youssef, Alysandratos, Padhorny, Ojha, Mora-Martin, Kretov, Ash, Verma, Zhao, Patten, Villacorta-Martin, Bolzan, Perea-Resa, Bullitt et al.: "Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. ..." in: Molecular cell, Vol. 80, Issue 6, pp. 1104-1122.e9, (2021) (PubMed).

Albecka, Clift, Vaysburd, Rhinesmith, Caddy, Favara, Baxendale, James: "A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein." in: The EMBO journal, Vol. 40, Issue 17, pp. e108588, (2021) (PubMed).

Papa, Mallery, Albecka, Welch, Cattin-Ortolá, Luptak, Paul, McMahon, Goodfellow, Carter, Munro, James: "Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion." in: PLoS pathogens, Vol. 17, Issue 1, pp. e1009246, (2021) (PubMed).

Jin, Nesbitt, Yang, Chen, Horowitz, Jones, Vandergaast, Carey, Reiter, Russell, Kyratsous, Hooper, Hamilton, Ferreira, Deng, Straus, Baras, Hillyer, Luchsinger: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).

Johnson, Drugan, Miller, Evans: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)

Synonyme und alternative Namen zu SARS-Coronavirus Nucleocapsid Protein

nucleocapsid protein (N), NC, Protein N

Bezeichner auf Proteinebene für SARS-Coronavirus Nucleocapsid Protein

  • Nucleocapsid protein
Sie sind hier:
Kundenservice